RGC 株価推移チャート
RGC 財務
Regencell Bioscience Holdings Ltd
$19.69
-3.71%
$-0.75
終値： Jun 11, 16:00:00 GMT-4
$19.58
-0.55%
$-0.11
アフターマーケット：Jun 11, 19:33:51 GMT-4
戻る
Regencell Bioscience Holdings Ltd (RGC) 財務
主要データ
前終値
$20.45
始値
$20.49
当日レンジ
$18.94 - $20.85
52週レンジ
$9.39 - $83.6
取引高
89.9K
平均取引高
142.9K
配当利回り
--
1株当たり利益(TTM)
-0.01
時価総額
$9.7B
RGCとは何ですか？
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
